tradingkey.logo

Milestone Pharmaceuticals Inc

MIST
View Detailed Chart

1.430USD

0.0000.00%
Close 08/01, 16:00ETQuotes delayed by 15 min
76.45MMarket Cap
LossP/E TTM

Milestone Pharmaceuticals Inc

1.430

0.0000.00%
Intraday
1m
30m
1h
D
W
M
D

Today

-1.38%

5 Days

-9.49%

1 Month

-26.29%

6 Months

-27.04%

Year to Date

-39.41%

1 Year

+6.72%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 4 analysts
BUY
Current Rating
3.333
Target Price
133.10%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

552
Total
5
Median
6
Average
Company name
Ratings
Analysts
Milestone Pharmaceuticals Inc
MIST
4
CRISPR Therapeutics AG
CRSP
29
Intellia Therapeutics Inc
NTLA
28
Ionis Pharmaceuticals Inc
IONS
27
Exact Sciences Corp
EXAS
27
IQVIA Holdings Inc
IQV
25
1
2
3
...
111

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Sell
Sell(9)
Neutral(1)
Buy(0)
Indicators
Sell(3)
Neutral(1)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.060
Sell
RSI(14)
40.510
Neutral
STOCH(KDJ)(9,3,3)
14.048
Oversold
ATR(14)
0.107
Low Volatility
CCI(14)
-119.583
Sell
Williams %R
90.909
Oversold
TRIX(12,20)
-0.882
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
1.468
Sell
MA10
1.512
Sell
MA20
1.691
Sell
MA50
1.703
Sell
MA100
1.507
Sell
MA200
1.690
Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Milestone Pharmaceuticals Inc. is a Canada-based biopharmaceutical company. The Company is focused on the development and commercialization of cardiovascular medicines. Its lead product candidate, etripamil, is a potent rapid-onset calcium channel blocker that the Company designed and is developing as a rapid-onset nasal spray to be administered by patients. The Company is also focused on developing etripamil to treat paroxysmal supraventricular tachycardia (PSVT) with a subsequent indication to treat atrial fibrillation with rapid ventricular rate (AFib-RVR) and other cardiovascular indications.
Ticker SymbolMIST
CompanyMilestone Pharmaceuticals Inc
CEOMr. Joseph Oliveto
Websitehttps://www.milestonepharma.com
KeyAI